Paolo Tarantino, Thibaut Sanglier, Elsa Garcia Hernandez, Tijana Krnjeta Janicijevic, Ibrahim Abbass. "Adjuvant antibody-drug conjugate (ADC) eligibility and corresponding prognosis in HER2+ early breast cancer (eBC): A US-based real-world comparison of KATHERINE and DESTINY-Breast05 populations.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.535